. Parameters 71-10 were estimated using our previous experimental work as detailed below.
Supplementary Text 1.4: Parameter Estimation for the LY30 + TRAIL Model
LY30-induced Receptor Oligomerization. Quantification of receptor oligomerization was conducted using our previous experiments that pulled down DR5 from HeLa lysate using excess or limited amounts of antibody . The total amount of DR5 protein was the same in LY30-treated cells and untreated, but the amount of DR5 pulled down by limited antibodies was 5.8-fold greater in LY30-treated cells than in untreated cells (Supplementary Figure 1. 4.1). If the pull-down ratio had been close to 3-fold, we might have characterized the transition as trimerization, because trimerization is receptor stoichiometry for activation. Instead we considered analogies to published results finding that clustered or oligomerized or lipid-raft-localized receptors transduce TRAIL signals more readily than non-clustered receptors (Mellier and Pervaiz, 2012) . For example, the DR clustering induced by LY30 resembles the lipid raft localization of DRs, induced by the ROS-producing compound resveratrol (Delmas, et al., 2004) . Therefore, we modeled DR5 oligomerization as a change of state. In untreated cells, all receptors were assumed to be initially an unprimed state R. We then modeled that receptor interaction with LY30 would trigger a state transition towards a cluster-localized state called R_primed. 
The rate parameters of this reaction were chosen so that an initial dose of R would reach steady state levels of R_primed at approximately 1 hour, and also so that the R:LY30 complex would have low concentration. DISC formation. For DISC formation, we retained the rates (k1, k_1, KK1) from Albeck et al. for unprimed receptors. For primed receptors, k40 was set to 1e-4 and and k_40
Supplementary Figure 1. 
LY30-induced receptor oligomerization. (a)
Experimental results reprinted from and (b) quantified density of the DR5 bands using ImageJ. The existing model was simulated to obtain the level of R* at 5 minutes after treatment with TRAIL alone. The experimentally measured fold-change in DISC-like complex formation at 5 minutes was used to compute an expected fold-change increase in R* for simulations of the LY+T treatment at 5 minutes. Then the KK40 parameter was adjusted so that simulations of LY+T would achieve the expected value of R* at 5 minutes.
Doses.
We stimulated the model with 1200 molecules/cell of TRAIL to represent 20ng/ml of TRAIL, consistent with prior use of 3000 molecules/cell to represent 50ng/ml of TRAIL. The dose of LY30 was not calibrated to physical units, and the dose-response of LY30 was not studied. Therefore, simulations of LY30 should either use zero dose, or else use the same unitless dose (4.1) that we used when calibrating the simulated downstream effects of LY30 on receptors and cFLIP. , where the parameter k_37 was estimated so that the simulated level of FLIP declined at 3 hrs to match the fold-change observed at 3hrs in our previously published experiments .
Caspase Rates. Non-specific reactions for synthesis and degradation were added manually with the rates specified. Then automated parameter optimization was performed with the KroneckerBio Toolbox, varying the reaction rates for the caspase enzymes, so that simulations of LY30 alone and simulations of TRAIL alone would match previously published time kinetics of Caspase-3 and Caspase-8 activity after treatment with LY30 alone and TRAIL alone .
LY30-induced ROS production.
As we did not know the exact mechanism behind the ROS production upon LY30 treatment, so we simulated a simplistic pseudo-reaction in which LY30 induces ROS production, 
Supplementary Text 1.6: Conversion of absolute activity into relative foldchange
The model is simulated using absolute protein levels, but Figure 4 shows simulations plotted as predictions of experimental observations in terms of relative enzyme activity. The caspase family of cysteine proteases can target different substrates according to structure. Caspase-8 activity is typically measured as the cleavage of the peptide IETD (Ile-Glu-Thr-Asp), using the fluorescence of Ac-IETD-AFC. Caspase-3 activity is typically measured as the cleavage of DEVD, using the fluorescence of Ac-Asp-Glu-ValAsp-pNA. Fluorescent substrates were purchased from (BioMol, Plymouth Meeting, PA, USA) and used according to manufacturer's instructions. McStay et al. found that commercial caspase substrates, such as the ones we used, are not entirely specific for their respective cysteine proteases (McStay, et al., 2008) , and there is overlapping cleavage motif selectivity. We converted our simulations of absolute protein levels into hypothetical IETD and DEVD fluorescence using a weighted combination of individual caspase levels, according to the quantification of overlap in (McStay, et al., 2008) . This ROS-cFLIP model is intended to represent multiple possible sources of ROS including NADPH oxidase. However, for specificity of kinetics, the reactions describe ROS production by mitochondrial respiratory chain complexes (Buettner, et al., 2006) .
